KDR and neoplasm: The current study demonstrated a mechanism whereby sMEK1 controls tumor angiogenesis by inhibiting p-eNOS (Ser-1179) and targeting the VEGFR-2/PI3K/eNOS signaling cascade in endothelial cells.